Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder
← Find more feeds

astrazeneca.com

Press releases

Get the latest updates from Press releases directly as they happen.

Follow now 75 followers

Latest posts

Last updated 5 days ago

Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer

6 days ago

Imfinzi plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive at three years

6 days ago

Enhertu granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen

7 days ago

AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data at ASCO GI and GU

11 days ago

AstraZeneca and Scorpion Therapeutics enter agreement to discover, develop and commercialise novel cancer treatments against ‘undruggable’ targets

11 days ago

New Vaxzevria data further support its use as third dose booster

11 days ago

AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006

17 days ago

Transfer of global rights for Eklira and Duaklir to Covis Pharma completed

19 days ago

AstraZeneca and Ionis close agreement to develop and commercialise eplontersen

26 days ago

Vaxzevria significantly boosted antibody levels against Omicron

about 1 month ago

Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in studies from Oxford and Washington Universities

about 1 month ago

Ultomiris regulatory submission accepted under FDA Priority Review in the US for adults with generalised myasthenia gravis

about 1 month ago

Sign up to continue

Try Feeder for free

Everything you care about in one place

Try Feeder now